| ID | Overall exception reporting | Population achievement | ||||||
---|---|---|---|---|---|---|---|---|---|
 | 2010–2011 | 2011–2012 | 2012–2013 | 2010–2011 | 2011–2012 | 2012–2013 | 2010–2011 | 2011–2012 | 2012–2013 |
Indicator | |||||||||
 BP 04 record of BPa | 0.78 | 0.88 | 1.09 | 1.87 | 1.79 | 2.26 | 91.30 | 91.21 | 91.21 |
 BP 05 last BPa ≤ 150/90 mmHg | 0.96 | 1.11 | 1.42 | 4.44 | 4.56 | 4.97 | 78.21 | 78.34 | 79.64 |
 COPD 08 influenza vaccine in the preceding 7 months | 1.85 | 1.99 | 2.19 | 13.76 | 13.33 | 12.68 | 81.51 | 81.82 | 82.26 |
 COPD 10 record of forced expiratory volume in 1 sb | 3.57 | 3.91 | 4.42 | 14.81 | 15.79 | 15.97 | 78.07 | 76.64 | 77.00 |
 COPD 13 review, including MRC (Medical Research Council) scoreb | 3.42 | 3.70 | 4.23 | 12.11 | 12.50 | 12.15 | 82.10 | 81.53 | 81.93 |
 DM 02 record of body mass indexb | 1.48 | 1.59 | 1.75 | 3.62 | 3.58 | 3.56 | 92.20 | 91.98 | 91.89 |
 DM 10 neuropathy testingb | 2.10 | 2.27 | 2.52 | 6.58 | 6.56 | 6.81 | 86.65 | 86.72 | 86.10 |
 DM 13 micro-albuminuria testingb | 2.24 | 2.47 | 2.56 | 5.67 | 5.53 | 5.78 | 87.23 | 87.12 | 86.32 |
 DM 17 last measured total cholesterol ≤ 5 mmol/Lb | 2.24 | 2.40 | 2.63 | 10.71 | 10.75 | 11.83 | 75.38 | 74.51 | 74.18 |
 DM 18 influenza vaccine in preceding 7 months | 2.16 | 2.17 | 2.42 | 16.02 | 15.41 | 14.80 | 78.26 | 78.66 | 78.49 |
 DM 21 retinal screeningb | 1.65 | 1.73 | 1.92 | 9.80 | 9.53 | 9.62 | 85.30 | 85.49 | 85.71 |
 DM 22 record of estimated glomerular filtration rate or creatinineb | 1.23 | 1.21 | 1.33 | 2.24 | 2.21 | 2.23 | 95.45 | 95.52 | 95.85 |
 STROKE 06 TIA or stroke with BPb ≤ 150/90 mmHg | 0.56 | 0.66 | 0.71 | 4.55 | 4.88 | 4.76 | 85.71 | 85.62 | 86.11 |
 STROKE 07 TIA or stroke with a record of total cholesterolb | 0.85 | 1.02 | 1.06 | 4.55 | 4.65 | 4.79 | 88.99 | 88.71 | 89.44 |
 STROKE 08 TIA or stroke with last measured total cholesterolb ≤ 5 mmol/L | 1.12 | 1.39 | 1.49 | 12.68 | 13.24 | 13.43 | 70.59 | 70.49 | 70.77 |
 STROKE10 TIA or stroke with influenza vaccine in preceding 7 months | 0.74 | 1.03 | 1.04 | 15.66 | 14.53 | 13.79 | 78.08 | 78.81 | 79.42 |
 EPILEP 08 ≥ 18 years old on drug treatment and seizure free for past 12 months | 1.16 | 1.92 | 2.08 | 24.00 | 24.32 | 25.00 | 58.73 | 58.62 | 57.41 |
 EPILEP 06 ≥ 18 years old on drug treatment with a record of seizure frequencyb | 0.00 | 0.00 | 0.00 | 4.00 | 4.94 | 5.00 | 91.30 | 90.57 | 91.09 |
 CHD 06 last BPb ≤ 150/90 mmHg | 0.75 | 0.71 | 0.64 | 3.29 | 3.17 | 3.33 | 88.41 | 87.94 | 88.60 |
 CHD 08 last total cholesterolb ≤ 5 mmol/L | 1.25 | 1.26 | 1.11 | 10.13 | 10.46 | 10.99 | 75.25 | 73.24 | 73.49 |
 CHD 12 influenza vaccine in preceding 7 months | 0.99 | 0.95 | 0.92 | 12.90 | 12.13 | 11.60 | 82.40 | 82.82 | 82.90 |
 CKD 02 record of BPb in those with CKD | 0.00 | 0.00 | 0.00 | 0.56 | 0.63 | 0.62 | 97.35 | 97.18 | 97.16 |
 CKD 03 last BPb ≤ 140/85 mmHg | 0.00 | 0.00 | 0.00 | 6.46 | 6.31 | 6.27 | 70.97 | 71.59 | 72.33 |
 CKD 06 record of urine albumin to creatinine ratio (or protein to creatinine ratio)b | 0.00 | 0.00 | 0.20 | 3.91 | 3.85 | 3.76 | 83.07 | 83.02 | 83.08 |
 DEM 02 care has been reviewedb in those with dementia | 0.00 | 0.00 | 0.00 | 5.56 | 5.17 | 6.25 | 75.68 | 76.77 | 78.33 |
 DEP 01 DM/CHD with depression screenb | 0.43 | 0.51 | 0.40 | 3.64 | 3.64 | 3.95 | 87.45 | 86.75 | 86.62 |
 PP 01 new hypertensive medication (without CHD, diabetes, stroke and/or TIA)c with a cardiovascular risk assessment using approved tool | 0.00 | 0.00 | 0.00 | 12.50 | 12.50 | 11.11 | 73.33 | 72.22 | 75.56 |
 PP 02 hypertensive medication; given lifestyle adviceb for physical activity, smoking, alcohol and healthy diet | 0.00 | 0.00 | 0.00 | 6.67 | 4.76 | 3.39 | 79.55 | 80.49 | 82.86 |
 THYROI 02 hypothyroidism with thyroid function testsb | 0.00 | 0.00 | 0.00 | 0.47 | 0.52 | 0.59 | 95.91 | 95.80 | 95.45 |
All indicators combined | 0.76 | 0.88 | 0.96 | 7.04 | 7.02 | 6.92 | 83.51 | 83.41 | 83.63 |